{
  "@context": "aku-v2",
  "@type": "device",
  "@id": "vascular:devices:drug-coated-balloon:definition",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T03:55:00.000Z",
    "updated": "2026-01-05T03:55:00.000Z",
    "contributors": ["copilot"],
    "status": "validated",
    "confidence": 0.92,
    "quality_score": 0.90
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/devices",
    "type": "device",
    "difficulty": "advanced",
    "importance": "core",
    "wikipedia_source": "Drug-eluting balloon"
  },
  "content": {
    "term": "Drug-Coated Balloon (DCB)",
    "definition": "An angioplasty balloon coated with an antiproliferative drug (typically paclitaxel 2-3 μg/mm²) that is transferred to the vessel wall during inflation, inhibiting neointimal hyperplasia without leaving a permanent implant. DCBs represent a 'leave nothing behind' philosophy for treating in-stent restenosis and femoropopliteal disease.",
    "clinical_features": {
      "snomed_ct": "445275003",
      "icd_10": "00.66",
      "drug_characteristics": [
        "Paclitaxel: most common, highly lipophilic",
        "Excipient (iopromide, urea): enhances drug transfer",
        "Dose: 2-3 μg/mm² balloon surface",
        "Contact time: 60-180 seconds inflation"
      ],
      "indications": [
        "In-stent restenosis (ISR) - Class I",
        "Femoropopliteal de novo lesions",
        "Below-knee intervention",
        "AV fistula stenosis",
        "Short segment focal stenosis"
      ],
      "technique_points": [
        "Pre-dilatation with plain balloon essential",
        "DCB sizing 1:1 with reference vessel",
        "Prolonged inflation 60-180 seconds",
        "No residual dissection before DCB"
      ],
      "evidence": [
        "IN.PACT Admiral: superior patency in femoropopliteal",
        "LEVANT 2: paclitaxel DCB vs PTA",
        "DEBATE-ISR: DCB for coronary ISR"
      ]
    },
    "board_yield": "HIGH",
    "clinical_pearls": [
      "DCB avoids permanent metal implant",
      "Optimal for in-stent restenosis where repeat stenting fails",
      "Pre-dilatation mandatory to ensure drug transfer",
      "Paclitaxel safety signal debated but currently FDA approved",
      "Drug-eluting stent still preferred for very long lesions"
    ]
  },
  "semantic_relations": {
    "broader": ["vascular:procedures:angioplasty"],
    "narrower": [],
    "related": ["vascular:procedures:stenting", "vascular:pathology:in-stent-restenosis"]
  },
  "pedagogy": {
    "learning_objectives": [
      "Describe mechanism of drug-coated balloon therapy",
      "Identify optimal lesions for DCB vs stent",
      "Understand proper DCB technique for maximal efficacy"
    ],
    "prerequisites": ["vascular:procedures:angioplasty", "vascular:procedures:stenting"]
  }
}
